← Back to Search

Sleep Management for Childhood Obesity

N/A
Recruiting
Led By Andrea B Goldschmidt, Ph.D.
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Must not have
Taking medication known to affect sleep/appetite (e.g., antihistamines, stimulants)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights

Summary

This trial will assess the effects of an experimental sleep manipulation on eating-related self-regulation and its neural substrates, and on real-world eating behavior, among children with overweight/obesity.

Who is the study for?
This trial is for children who are overweight or obese and willing to have an MRI scan. It's not suitable for those with conditions affecting brain function, like a recent concussion, more than 10 hours of sleep per night, past eating disorders, sleep or psychiatric conditions, or if they're on medications that affect sleep or appetite.
What is being tested?
Project REST aims to see how changing the amount of sleep can influence children's self-control around eating and their brain activity related to food. The study will test whether more or less sleep affects real-world eating behavior in kids with weight issues.
What are the potential side effects?
Since this trial involves changes in sleeping patterns rather than medication, side effects may include tiredness from lack of sleep during the restriction phase and potential difficulty adjusting to new sleeping schedules.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am taking medication that can affect my sleep or appetite.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Eating Behavior
Change in Weight Status
Self-Regulatory Control
Secondary study objectives
Sleep Patterns

Trial Design

2Treatment groups
Experimental Treatment
Group I: Sleep restriction followed by extensionExperimental Treatment2 Interventions
Children will spend 8 hours in bed for one week, engage in one week of wash-out, and then spend 11 hours in bed for one week.
Group II: Sleep extension followed by restrictionExperimental Treatment2 Interventions
Children will spend 11 hours in bed for one week, engage in one week of wash-out, and then spend 8 hours in bed for one week.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sleep extension
2019
N/A
~180
Sleep restriction
2005
Completed Phase 1
~450

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,762 Previous Clinical Trials
16,347,883 Total Patients Enrolled
14 Trials studying Sleep
1,966 Patients Enrolled for Sleep
The Miriam HospitalLead Sponsor
243 Previous Clinical Trials
37,587 Total Patients Enrolled
5 Trials studying Sleep
892 Patients Enrolled for Sleep
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,889 Previous Clinical Trials
47,834,087 Total Patients Enrolled
32 Trials studying Sleep
57,025 Patients Enrolled for Sleep

Media Library

Sleep extension Clinical Trial Eligibility Overview. Trial Name: NCT04057716 — N/A
Sleep Research Study Groups: Sleep restriction followed by extension, Sleep extension followed by restriction
Sleep Clinical Trial 2023: Sleep extension Highlights & Side Effects. Trial Name: NCT04057716 — N/A
Sleep extension 2023 Treatment Timeline for Medical Study. Trial Name: NCT04057716 — N/A
~14 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top